Background: Transcatheter mitral valve repair (TMVr), using MitraClip®, is a safe and effective procedure for severe mitral valve regurgitation (MR). However, the therapeutic results of MitraClip® in Qatar remain to be elucidated. A total of 25 patients (mean age 60 ± 14.5 years, 64% males) with symptomatic severe MR and prohibitive surgical risks were enrolled in this study. The procedural success rate was 92% to achieve mild residual MR. There was no periprocedural death. All patients experienced significant improvement in heart failure symptoms and MR grade postprocedure with sustained improvement over 1-year follow-up.Conclusion: The TMVr procedure using the MitraClip® device was safe and resulted in meaningful and sustained functional status and echocardiographic parameter improvement.
{"title":"Transcatheter mitral valve repair with Mitraclip<sup>®</sup>: A nationwide experience","authors":"Mohammed Al-Hijji, ShabibAbdulah Al-Asmi, Rasha Kaddoura, MohammedSalah Abdelghani, Ashraf Ahmed, CheikAbdoul Maaly, Hakam Alzaeem, Nazar Mohammed, Mohanad Shehadeh, FahadAbdullah Al-Kindi, Awad Al-Qahtani","doi":"10.4103/heartviews.heartviews_90_23","DOIUrl":"https://doi.org/10.4103/heartviews.heartviews_90_23","url":null,"abstract":"Background: Transcatheter mitral valve repair (TMVr), using MitraClip®, is a safe and effective procedure for severe mitral valve regurgitation (MR). However, the therapeutic results of MitraClip® in Qatar remain to be elucidated. A total of 25 patients (mean age 60 ± 14.5 years, 64% males) with symptomatic severe MR and prohibitive surgical risks were enrolled in this study. The procedural success rate was 92% to achieve mild residual MR. There was no periprocedural death. All patients experienced significant improvement in heart failure symptoms and MR grade postprocedure with sustained improvement over 1-year follow-up.Conclusion: The TMVr procedure using the MitraClip® device was safe and resulted in meaningful and sustained functional status and echocardiographic parameter improvement.","PeriodicalId":32654,"journal":{"name":"Heart Views","volume":"364 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134982103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.4103/heartviews.heartviews_31_23
Anuradha Sharma, Ekta Chourasia, Shubham Goswami
Background: Point of care tests provide rapid information about the patient's condition, with a turnaround time of 15 min. During the COVID-19 pandemic, many such point of care tests were developed, to aid in the rapid diagnosis of SARS-Cov-2 infection.Aim: To describe and synthesize the available literature on point of care tests for diagnosis of SARS-CoV-2.Methodology: This narrative review was done through online literature search,using Google Scholar and PubMed.Result: There were 51 point of care tests for diagnosis of SARS-CoV-2 which were validated using different samples,such as such as nasopharyngeal swabs(42), oropharyngeal and naso-pharyngealswabs(2), oropharyngeal swab in VTM(1) nasal swabs(5) and throat swab(1).Conclusion: There was global developement of point of care tests on a war footing. The Indian states of Delhi, Maharashtra, Gujarat, Uttar Pradesh, Tamil Nadu, Karnataka, Haryana, Rajasthan, Kerala, Himachal Pradesh, Goa and Uttarakhand, were in the forefront of these developments, as also the USA, Belgium, Taiwan, Korea and South Korea.
{"title":"Point of care tests: Changing paradigms in the diagnosis of SARS-CoV-2","authors":"Anuradha Sharma, Ekta Chourasia, Shubham Goswami","doi":"10.4103/heartviews.heartviews_31_23","DOIUrl":"https://doi.org/10.4103/heartviews.heartviews_31_23","url":null,"abstract":"Background: Point of care tests provide rapid information about the patient's condition, with a turnaround time of 15 min. During the COVID-19 pandemic, many such point of care tests were developed, to aid in the rapid diagnosis of SARS-Cov-2 infection.Aim: To describe and synthesize the available literature on point of care tests for diagnosis of SARS-CoV-2.Methodology: This narrative review was done through online literature search,using Google Scholar and PubMed.Result: There were 51 point of care tests for diagnosis of SARS-CoV-2 which were validated using different samples,such as such as nasopharyngeal swabs(42), oropharyngeal and naso-pharyngealswabs(2), oropharyngeal swab in VTM(1) nasal swabs(5) and throat swab(1).Conclusion: There was global developement of point of care tests on a war footing. The Indian states of Delhi, Maharashtra, Gujarat, Uttar Pradesh, Tamil Nadu, Karnataka, Haryana, Rajasthan, Kerala, Himachal Pradesh, Goa and Uttarakhand, were in the forefront of these developments, as also the USA, Belgium, Taiwan, Korea and South Korea.","PeriodicalId":32654,"journal":{"name":"Heart Views","volume":"364 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134982098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Although respiratory support is necessary to maintain hemodynamic stability in patients undergoing major surgeries, prolonging the time of mechanical ventilation is considered a major complication following these procedures. The identification of potential factors related to this phenomenon should be identified. In the present systematic review, we first assess the pooled prevalence of prolonged mechanical ventilation (PMV) in patients undergoing coronary artery bypass grafting (CABG) surgery and also determine the main predictors for PMV by deeply reviewing the literature.Materials and Methods: The manuscript databases including Medline, Web of Knowledge, Google Scholar, Scopus, and Cochrane were deeply searched by the two blinded investigators for all eligible studies based on the relevant keywords. Based on the titles and abstracts, 88 records were initially included and of those, 15 articles were eligible for the final analysis.Results: The pooled prevalence of PMV in the studies that defined PMV as ventilation >24 h was 6.5% (95% confidence interval [CI]: 4.1%–10.2%) and in the studies, PMV as ventilation >48 h was 2.8% (95% CI: 1.7%–4.7%). Demographics (gender and advanced age), obesity, underlying comorbidities (hypertension, chronic kidney disease, cerebrovascular accident, high New York Heart Association class, history of chronic obstructive pulmonary disease, and history of acute coronary syndrome), emergency surgery, intraoperative characteristics (needing intra-aortic balloon pump, increased peak airway pressure, using cardiopulmonary bypass, the type of dose of anesthetics, cross-clamp time, increased units of blood transfusion, occurring cardiac ischemic events within an operation, fluid imbalance, and some anastomoses), and some postoperative outcome such as lowering O2 saturation, sequential organ failure assessment score, inotrope use, pleural effusion, delirium, and prolonged intensive care unit stay were found to be the main determinants for PMV.Conclusion: Depending on the definition of PMV, the prevalence of PMV varied from 1.7% to 10.2%. Various factors before, during, and after surgery are the predictors of PMV in these patients, which can be used to design new scoring systems to predict it.
背景:虽然呼吸支持对于维持大手术患者的血流动力学稳定是必要的，但延长机械通气时间被认为是这些手术后的主要并发症。应确定与这一现象有关的潜在因素。在本系统综述中，我们首先评估了冠状动脉旁路移植术(CABG)患者中延长机械通气(PMV)的总体患病率，并通过深入查阅文献确定了PMV的主要预测因素。材料与方法:两位盲法研究者根据相关关键词对Medline、Web of Knowledge、Google Scholar、Scopus和Cochrane等文献数据库进行深度检索，找到所有符合条件的研究。根据标题和摘要，最初纳入了88条记录，其中15条符合最后分析的条件。结果:在将PMV定义为通气>24 h的研究中，PMV的总患病率为6.5%(95%可信区间[CI]: 4.1%-10.2%)，在将PMV定义为通气>48 h的研究中，PMV的总患病率为2.8% (95% CI: 1.7%-4.7%)。人口统计学(性别和高龄)、肥胖、潜在合并症(高血压、慢性肾病、脑血管意外、纽约心脏协会高分级、慢性阻塞性肺病史、急性冠状动脉综合征史)、急诊手术、术中特征(需要主动脉内球囊泵、气道压力峰值升高、使用体外循环、麻醉药剂量类型、交叉钳夹时间、输血次数增加、手术中发生的心脏缺血事件、体液失衡和一些吻合)，以及一些术后结果，如氧饱和度降低、序贯器官衰竭评估评分、使用肌力、胸腔积液、谵妄和延长重症监护病房时间，被发现是PMV的主要决定因素。结论:根据PMV的定义，PMV的患病率从1.7%到10.2%不等。术前、术中、术后的各种因素是这些患者PMV的预测因子，可用于设计新的评分系统来预测PMV。
{"title":"The overall prevalence and main determinants of prolonged mechanical ventilation in patients undergoing coronary artery bypass grafting: A systematic review","authors":"Fahim Khajehbahrami, Farzad Shahsanaei, Soudabeh Behrooj, NimaRahimi Petrudi","doi":"10.4103/heartviews.heartviews_71_23","DOIUrl":"https://doi.org/10.4103/heartviews.heartviews_71_23","url":null,"abstract":"Background: Although respiratory support is necessary to maintain hemodynamic stability in patients undergoing major surgeries, prolonging the time of mechanical ventilation is considered a major complication following these procedures. The identification of potential factors related to this phenomenon should be identified. In the present systematic review, we first assess the pooled prevalence of prolonged mechanical ventilation (PMV) in patients undergoing coronary artery bypass grafting (CABG) surgery and also determine the main predictors for PMV by deeply reviewing the literature.Materials and Methods: The manuscript databases including Medline, Web of Knowledge, Google Scholar, Scopus, and Cochrane were deeply searched by the two blinded investigators for all eligible studies based on the relevant keywords. Based on the titles and abstracts, 88 records were initially included and of those, 15 articles were eligible for the final analysis.Results: The pooled prevalence of PMV in the studies that defined PMV as ventilation >24 h was 6.5% (95% confidence interval [CI]: 4.1%–10.2%) and in the studies, PMV as ventilation >48 h was 2.8% (95% CI: 1.7%–4.7%). Demographics (gender and advanced age), obesity, underlying comorbidities (hypertension, chronic kidney disease, cerebrovascular accident, high New York Heart Association class, history of chronic obstructive pulmonary disease, and history of acute coronary syndrome), emergency surgery, intraoperative characteristics (needing intra-aortic balloon pump, increased peak airway pressure, using cardiopulmonary bypass, the type of dose of anesthetics, cross-clamp time, increased units of blood transfusion, occurring cardiac ischemic events within an operation, fluid imbalance, and some anastomoses), and some postoperative outcome such as lowering O2 saturation, sequential organ failure assessment score, inotrope use, pleural effusion, delirium, and prolonged intensive care unit stay were found to be the main determinants for PMV.Conclusion: Depending on the definition of PMV, the prevalence of PMV varied from 1.7% to 10.2%. Various factors before, during, and after surgery are the predictors of PMV in these patients, which can be used to design new scoring systems to predict it.","PeriodicalId":32654,"journal":{"name":"Heart Views","volume":"25 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134982100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Acute coronary syndromes (ACSs) present most frequently with chest pain, but angina equivalents such as dyspnea, diaphoresis, and fatigue are not uncommon. Atypical presentations are especially seen in women, the elderly, and diabetics. Cardiac evaluation using a transthoracic echocardiogram is almost always done before or immediately after someone undergoes left heart catheterization for ACS. It provides information valuable information regarding wall motion, left ventricular systolic function, diastolic function, right ventricular involvement, pulmonary pressures, incidental valvular disease, pericardial fluid, or any other unsuspected abnormality. We describe a novel case where an atypical presentation of ACS was suspected based on the lack of intravenous contrast administered, to enhance endocardial border resolution. The use of contrast during echocardiography has been used during stress protocols to assess microcirculation during perfusion assessment studies. However, we described a reduced uptake during the acquisition of resting myocardial echocardiogram images and it was very useful to direct therapy.
{"title":"Abnormal resting myocardial contrast echocardiographic uptake: Clue of an ongoing acute coronary artery event","authors":"Angel López-Candales, RoopeshSai Jakulla, SatyaPreetham Gunta","doi":"10.4103/heartviews.heartviews_32_23","DOIUrl":"https://doi.org/10.4103/heartviews.heartviews_32_23","url":null,"abstract":"Acute coronary syndromes (ACSs) present most frequently with chest pain, but angina equivalents such as dyspnea, diaphoresis, and fatigue are not uncommon. Atypical presentations are especially seen in women, the elderly, and diabetics. Cardiac evaluation using a transthoracic echocardiogram is almost always done before or immediately after someone undergoes left heart catheterization for ACS. It provides information valuable information regarding wall motion, left ventricular systolic function, diastolic function, right ventricular involvement, pulmonary pressures, incidental valvular disease, pericardial fluid, or any other unsuspected abnormality. We describe a novel case where an atypical presentation of ACS was suspected based on the lack of intravenous contrast administered, to enhance endocardial border resolution. The use of contrast during echocardiography has been used during stress protocols to assess microcirculation during perfusion assessment studies. However, we described a reduced uptake during the acquisition of resting myocardial echocardiogram images and it was very useful to direct therapy.","PeriodicalId":32654,"journal":{"name":"Heart Views","volume":"142 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135445604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.4103/heartviews.heartviews_26_23
HajarAhmed Hajar Albinali, Rajvir Singh, OmniaTajelsir Abdalla Osman, AbdulRahman Al Arabi, Betsy Varughese, Awad Al Qahtani, Nidal Asaad, Jassim Al Suwaidi
Introduction: Studies from the US and Europe showed a decline in smoking among patients with acute myocardial infarction (AMI), but limited data are available from the Middle East. In this study, we describe the temporal trend in the prevalence, associated risk factors, and outcomes of smoking among patients with AMI in Qatar.Materials and Methods: A total of 27,648 AMI patients were analyzed from the cardiology registry at Heart Hospital, Doha, Qatar. This spans from January 1991 to May 2022.Results: Of the total, 13,562 patients (49.1%, 95% confidence interval [CI]: 48%–50%) were smokers, with a clear majority of males (98.5%). Smoking habit was found to decrease in AMI patients with increasing age (age 51–60 years, adjusted odds ratio [OR]: 0.71, 95% CI: 0.67–0.76, P = 0.001, and age ≥61 years, adjusted OR: 0.45, 95% CI: 0.42–0.48, P = 0.001, in comparison to age ≤50 years). Smoking was associated with a lower risk of inhospital mortality (adjusted OR: 0.61, 95% CI: 0.54–0.70, P = 0.001), but triglyceride, obesity, and old myocardial infarction risk factors were associated with a higher risk. A decreasing trend in current smoking habits in each quantile of the 1996–2000 year (adjusted OR: 0.82, 95% CI: 0.71–0.93, P = 0.001), 2001–2005 year (adjusted OR: 0.70, 95% CI: 0.62–0.80, P = 0.001), 2006–2010 year (adjusted OR: 0.75, 95% CI: 0.67–0.84, P = 0.001), 2011–2015 year (adjusted OR: 0.48, 95% CI: 0.42–0.54, P = 0.001), 2016–2020 year (adjusted OR: 0.48, 95% CI: 0.43–0.54, P = 0.001), and ≥2021 year (adjusted OR: 0.46, 95% CI: 0.40–0.53, P = 0.001) was observed in comparison to the quantile 1991–1995 year. Similar results were also observed in the young population (age ≤50 years) including the non-Qataris, who had 25% more smokers in comparison to Qatari nationals.Conclusion: Smoking trended down significantly; however, it remained prevalent in 50% of patients among AMI patients. Smokers were younger, with fewer traditional risk factors, and had lower inhospital mortality.
来自美国和欧洲的研究表明，急性心肌梗死(AMI)患者的吸烟率下降，但来自中东的数据有限。在这项研究中，我们描述了卡塔尔AMI患者中吸烟的流行率、相关危险因素和结果的时间趋势。材料和方法:对来自卡塔尔多哈心脏医院心脏病学登记的27,648例AMI患者进行分析。这段时间从1991年1月到2022年5月。结果:13562例(49.1%，95%可信区间[CI]: 48% ~ 50%)患者为吸烟者，其中男性占明显多数(98.5%)。与年龄≤50岁的AMI患者相比，随着年龄的增加(51 ~ 60岁，校正优势比[OR]: 0.71, 95% CI: 0.67 ~ 0.76, P = 0.001，年龄≥61岁，校正优势比[OR]: 0.45, 95% CI: 0.42 ~ 0.48, P = 0.001)，吸烟习惯减少。吸烟与较低的住院死亡风险相关(调整后的OR: 0.61, 95% CI: 0.54-0.70, P = 0.001)，但甘油三酯、肥胖和老年性心肌梗死风险因素与较高的风险相关。1996-2000年(校正OR: 0.82, 95% CI: 0.71-0.93, P = 0.001)、2001-2005年(校正OR: 0.70, 95% CI: 0.62-0.80, P = 0.001)、2006-2010年(校正OR: 0.75, 95% CI: 0.67-0.84, P = 0.001)、2011-2015年(校正OR: 0.48, 95% CI: 0.42-0.54, P = 0.001)、2016-2020年(校正OR: 0.48, 95% CI: 0.43-0.54, P = 0.001)和≥2021年(校正OR: 0.46, 95% CI: 0.43-0.54, P = 0.001)各分位数当前吸烟习惯的下降趋势:0.40-0.53, P = 0.001)，与1991-1995年的分位数相比。在年轻人群(年龄≤50岁)中也观察到类似的结果，包括非卡塔尔人，他们的吸烟者比卡塔尔国民多25%。结论:吸烟趋势明显下降;然而，它在50%的AMI患者中仍然普遍存在。吸烟者更年轻，传统的危险因素更少，住院死亡率也更低。
{"title":"Smoking in acute myocardial infarction patients: Observations from a registry heart hospital, Qatar","authors":"HajarAhmed Hajar Albinali, Rajvir Singh, OmniaTajelsir Abdalla Osman, AbdulRahman Al Arabi, Betsy Varughese, Awad Al Qahtani, Nidal Asaad, Jassim Al Suwaidi","doi":"10.4103/heartviews.heartviews_26_23","DOIUrl":"https://doi.org/10.4103/heartviews.heartviews_26_23","url":null,"abstract":"Introduction: Studies from the US and Europe showed a decline in smoking among patients with acute myocardial infarction (AMI), but limited data are available from the Middle East. In this study, we describe the temporal trend in the prevalence, associated risk factors, and outcomes of smoking among patients with AMI in Qatar.Materials and Methods: A total of 27,648 AMI patients were analyzed from the cardiology registry at Heart Hospital, Doha, Qatar. This spans from January 1991 to May 2022.Results: Of the total, 13,562 patients (49.1%, 95% confidence interval [CI]: 48%–50%) were smokers, with a clear majority of males (98.5%). Smoking habit was found to decrease in AMI patients with increasing age (age 51–60 years, adjusted odds ratio [OR]: 0.71, 95% CI: 0.67–0.76, P = 0.001, and age ≥61 years, adjusted OR: 0.45, 95% CI: 0.42–0.48, P = 0.001, in comparison to age ≤50 years). Smoking was associated with a lower risk of inhospital mortality (adjusted OR: 0.61, 95% CI: 0.54–0.70, P = 0.001), but triglyceride, obesity, and old myocardial infarction risk factors were associated with a higher risk. A decreasing trend in current smoking habits in each quantile of the 1996–2000 year (adjusted OR: 0.82, 95% CI: 0.71–0.93, P = 0.001), 2001–2005 year (adjusted OR: 0.70, 95% CI: 0.62–0.80, P = 0.001), 2006–2010 year (adjusted OR: 0.75, 95% CI: 0.67–0.84, P = 0.001), 2011–2015 year (adjusted OR: 0.48, 95% CI: 0.42–0.54, P = 0.001), 2016–2020 year (adjusted OR: 0.48, 95% CI: 0.43–0.54, P = 0.001), and ≥2021 year (adjusted OR: 0.46, 95% CI: 0.40–0.53, P = 0.001) was observed in comparison to the quantile 1991–1995 year. Similar results were also observed in the young population (age ≤50 years) including the non-Qataris, who had 25% more smokers in comparison to Qatari nationals.Conclusion: Smoking trended down significantly; however, it remained prevalent in 50% of patients among AMI patients. Smokers were younger, with fewer traditional risk factors, and had lower inhospital mortality.","PeriodicalId":32654,"journal":{"name":"Heart Views","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134982102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.4103/heartviews.heartviews_20_23
Cihan Bedel, Fatih Selvi, Bora Baltacioglu, Günay Yıldız
Ticagrelor is available as an oral antiplatelet agent that can bind reversibly to the adenosine diphosphate receptor P2Y12 on platelets without first having to be activated. Main side effects such as dizziness, bleeding gums, nausea in common, difficulty in speaking, fever, and change in mental status are rare. Herein, we report a patient who had seizures after the usage of ticagrelor.
{"title":"A case of ticagrelor-induced seizure","authors":"Cihan Bedel, Fatih Selvi, Bora Baltacioglu, Günay Yıldız","doi":"10.4103/heartviews.heartviews_20_23","DOIUrl":"https://doi.org/10.4103/heartviews.heartviews_20_23","url":null,"abstract":"Ticagrelor is available as an oral antiplatelet agent that can bind reversibly to the adenosine diphosphate receptor P2Y12 on platelets without first having to be activated. Main side effects such as dizziness, bleeding gums, nausea in common, difficulty in speaking, fever, and change in mental status are rare. Herein, we report a patient who had seizures after the usage of ticagrelor.","PeriodicalId":32654,"journal":{"name":"Heart Views","volume":"156 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135445632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-07-01DOI: 10.4103/HEARTVIEWS.HEARTVIEWS_74_19
Dawoud I. Al Kindi, F. Al Kindi
Coronary stent dislodgment and embolization are rare and challenging complications of percutaneous coronary intervention that may result in serious and fatal complications attributed to the loss of blood flow of the coronary, cerebral, or peripheral circulations. Percutaneous management is successful in most cases using different techniques and devices, but surgery may be required. We report two cases of stent dislodgment during primary PCI for the right coronary artery with different management approaches and outcomes.
{"title":"Right Coronary Artery Stent Dislodgment during Primary Percutaneous Coronary Intervention. To Leave or to Retrieve?","authors":"Dawoud I. Al Kindi, F. Al Kindi","doi":"10.4103/HEARTVIEWS.HEARTVIEWS_74_19","DOIUrl":"https://doi.org/10.4103/HEARTVIEWS.HEARTVIEWS_74_19","url":null,"abstract":"Coronary stent dislodgment and embolization are rare and challenging complications of percutaneous coronary intervention that may result in serious and fatal complications attributed to the loss of blood flow of the coronary, cerebral, or peripheral circulations. Percutaneous management is successful in most cases using different techniques and devices, but surgery may be required. We report two cases of stent dislodgment during primary PCI for the right coronary artery with different management approaches and outcomes.","PeriodicalId":32654,"journal":{"name":"Heart Views","volume":"20 1","pages":"109 - 113"},"PeriodicalIF":0.5,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70735908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：